References
- Calin G A, Pekarsky Y, Croce C M. The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract Res Clin Haematol 2007; 20: 425–437
- Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, Tavolaro S, et al. Quantitative technologies establish a novel miRNA profile of chronic lymphocytic leukemia. Blood 2007; 109: 4944–4951
- Marton S, Garcia M R, Robello C, Persson H, Trajtenberg F, Pritsch O, et al. Small RNAs analysis in CLL reveals a deregulation of miRNA expression and novel miRNA candidates of putative relevance in CLL pathogenesis. Leukemia 2008; 22: 330–338
- Chen C Z, Li L, Lodish H F, Bartel D P. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83–86
- Mott J L, Kobayashi S, Bronk S F, Gores G J. mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007; 26: 6133–6140
- Longo P G, Laurenti L, Gobessi S, Sica S, Leone G, Efremov D G. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells. Blood 2008; 111: 846–855
- He L, He X, Lowe S W, Hannon G J. microRNAs join the p53 network-another piece in the tumour-suppression puzzle. Nat Rev Cancer 2007; 7: 819–822
- Mraz M, Malinova K, Kotaskova J, Pavlova S, Tichy B, Malcikova J, et al. MiR-34a, miR-29c and miR-17-5p are down-regulated in CLL patients with Tp53 abnormalities. Leukemia, in press, [Epub ahead of print, Jan 2009]
- Zenz T, Mohr J, Eldering E, Kater A P, Bühler A, Kiele D, et al. Mir-34a as part of the chemotherapy resistance network in chronic lymphocytic leukemia. Blood, in press, [Epub ahead of print]
- O'Donnell K A, Wentzel E A, Zeller K I, Dang C V, Mendell J T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005; 435: 839–843